• 1. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 2. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 3. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 4. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 5. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161

Recent Advances in the Study of 3-(3-Nitrophenyl)-1H-pyrazole-4-carbaldehyde (CAS: 26033-25-0) in Chemical Biology and Pharmaceutical Research

3-(3-Nitrophenyl)-1H-pyrazole-4-carbaldehyde (CAS: 26033-25-0) is a heterocyclic compound that has garnered significant attention in recent years due to its potential applications in medicinal chemistry and drug discovery. This compound belongs to the pyrazole family, which is known for its diverse pharmacological activities. The presence of a nitro group and an aldehyde functionality in its structure makes it a versatile intermediate for the synthesis of various bioactive molecules. Recent studies have explored its role as a building block for the development of novel therapeutic agents targeting a range of diseases, including cancer, infectious diseases, and neurological disorders.

One of the key areas of research involving 3-(3-Nitrophenyl)-1H-pyrazole-4-carbaldehyde is its use in the synthesis of kinase inhibitors. Kinases are critical enzymes involved in signal transduction pathways, and their dysregulation is often associated with cancer and other diseases. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of this compound exhibited potent inhibitory activity against several tyrosine kinases, including EGFR and VEGFR2. The researchers utilized molecular docking and in vitro assays to elucidate the binding interactions and optimize the lead compounds for improved efficacy and selectivity.

In addition to its role in kinase inhibition, 3-(3-Nitrophenyl)-1H-pyrazole-4-carbaldehyde has also been investigated for its antimicrobial properties. A recent study in the European Journal of Medicinal Chemistry reported that novel Schiff base derivatives synthesized from this compound displayed significant activity against multidrug-resistant bacterial strains, such as MRSA and Escherichia coli. The study highlighted the importance of the nitro group in enhancing the antibacterial efficacy, possibly by facilitating interactions with bacterial enzymes or cell wall components.

Another promising application of this compound is in the field of neurodegenerative disease research. A 2022 study in Bioorganic & Medicinal Chemistry Letters explored its potential as a scaffold for developing small-molecule modulators of amyloid-beta aggregation, a hallmark of Alzheimer's disease. The researchers found that certain derivatives could effectively disrupt amyloid-beta fibril formation in vitro, suggesting a potential therapeutic avenue for Alzheimer's treatment. Further in vivo studies are warranted to validate these findings.

The synthetic versatility of 3-(3-Nitrophenyl)-1H-pyrazole-4-carbaldehyde has also been leveraged in the development of fluorescent probes for biological imaging. A 2023 publication in ACS Chemical Biology described the design of a pyrazole-based fluorescent probe derived from this compound, which exhibited high selectivity for reactive oxygen species (ROS) in live cells. This probe could be a valuable tool for studying oxidative stress-related pathologies, such as inflammation and cancer.

Despite these advancements, challenges remain in the optimization of 3-(3-Nitrophenyl)-1H-pyrazole-4-carbaldehyde derivatives for clinical applications. Issues such as pharmacokinetic properties, toxicity profiles, and scalability of synthesis need to be addressed in future studies. Collaborative efforts between chemists, biologists, and pharmacologists will be essential to translate these findings into viable therapeutic candidates.

In conclusion, 3-(3-Nitrophenyl)-1H-pyrazole-4-carbaldehyde (CAS: 26033-25-0) represents a promising scaffold in chemical biology and pharmaceutical research. Its diverse applications, ranging from kinase inhibition to antimicrobial activity and neurodegenerative disease modulation, underscore its potential as a versatile building block for drug discovery. Continued research efforts will likely uncover new therapeutic opportunities and further elucidate its mechanistic underpinnings.

• 35581-31-8(1H-Pyrazole-4-carboxylicacid, 3-(4-nitrophenyl)-)
• 660423-78-9(Pyridazine, 5-(3-nitrophenyl)-3-phenyl-)
• 26033-23-8(1H-Pyrazole-4-carboxaldehyde, 3-(4-nitrophenyl)-)
• 21487-49-0(3-(4-Nitrophenyl)-1-phenyl-1H-pyrazole-4-carbaldehyde)
• 59843-77-5(3-(3-Nitrophenyl)-1H-pyrazole)
• 448187-56-2(3-(3-Nitrophenyl)-1H-pyrazole-4-carboxylic acid)
• 333327-63-2(3-(3-NITROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE)
• 618098-92-3(3-(4-NITROPHENYL)-1-P-TOLYL-1H-PYRAZOLE-4-CARBALDEHYDE)
• 21487-51-4(1H-Pyrazole-4-carboxaldehyde, 1-(4-nitrophenyl)-3-phenyl-)
• 618098-91-2(3-(3-nitrophenyl)-1-p-tolyl-1h-pyrazole-4-carbaldehyde)